Dr. Reddy's Laboratories has secured a key regulatory win as its semaglutide injection receives approval from Health Canada, marking a major step in the global rollout of lower-cost alternatives to blockbuster diabetes and weight-loss drugs.
Aurigene Pharmaceutical Services is set to invest nearly $100 million investment to expand its CRDMO business, strengthening its role in the growing pharmaceutical outsourcing market.
Pfizer has reached agreements with several generic drug manufacturers that will allow its heart medicine Vyndamax to remain free from generic competition in the United States until 2031. The move gives the company more time to maintain stron...
Artificial intelligence-focused biotech company Profluent has partnered with pharmaceutical major Eli Lilly and Company in a genetic medicine deal worth up to $2.25 billion. The collaboration aims to develop advanced gene-editing therapi...
India stands at the heart of the Oxford malaria vaccine pact, as the Serum Institute of India joins hands with the University of Oxford to push forward a next-generation malaria vaccine candidate, R78C. The partnership puts India in a key...
Eli Lilly and Company is making a fresh move in blood cancer treatment with its plan to acquire Ajax Therapeutics for up to USD 2.3 billion. The deal shows how Eli Lilly is doubling down on blood cancer therapies as it looks to build a stronger...
Johnson & Johnson is using AI to accelerate drug discovery efforts, saying the technology has cut the time needed to generate early-stage drug development leads by half. The company revealed that AI drug discovery tools are helping researchers...
Akums Drugs & Pharmaceuticals Limited has announced the launch of Aztreonam-Avibactam Injection, a new antibiotic therapy designed to tackle multidrug-resistant gram-negative bacterial infections. The move comes at a time when rising...
Apollo Athenaa has launched an integrated robotic gynae-oncology ecosystem to improve treatment and care for women diagnosed with reproductive cancers. The initiative aims to address gaps in women’s cancer care by bringing together diagnosi...
The European Commission has approved Novartis Rhapsido (remibrutinib treatment) for adults suffering from chronic spontaneous urticaria (CSU treatment) who do not respond well to antihistamines. The European Commission approval gives patien...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")